“Biopharmaceuticals Manufacturing Consumables Testing Market Report is set to have rapid growth due to technological advancements and changing or improving regulatory requirements for analysis of raw materials required during biologics manufacturing at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Biopharmaceuticals Manufacturing Consumables Testing Market: Forecast 2019-2029: By Service (Compendial Testing, Laboratory Testing), By Raw Material Type (Excipients, API), Regions and segmental analysis.
Effective and successful biopharmaceutical production largely depends on the purity and quality of consumables used during production. With increasing problems related to the quality of new therapies such as poor solubility, increased molecular size and poor absorption properties, there is an increase in attention in the exploration of the various attributes of excipients and other raw materials.
The rapid growth of the bio pharmaceutical industry has made it necessary to keep pace with the change or improvement of regulatory requirements for the analysis of raw materials required during organic production. Consequently, manufacturers of final products require the support of the supplier qualification program to validate whether the services offered by the supplier are in compliance with the complementary monographs. This led the segment to support the supplier qualification program based on compendial methods. In addition, technological advances in analytical technologies have provided suppliers with improved capabilities to test proteins, raw materials, cell lines and other consumables used during the production of large molecules. Advances in portable Raman spectroscopy methods are one of the significant developments in this market. Agilent Technologies is one of the companies that offers products based on the principle of Raman spectroscopy.
Leading companies featured in the report include Alcami Corporation; Merck KGaA; Eurofins Scientific; Agilent Technologies; Charles River; Catalent, Inc.; Avomeen Analytical Services; BioSpectra; Pace Analytical Services, LLC and Gibraltar Laboratories
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand for cellular immunotherapies.
15 June 2021
Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.
14 June 2021
Rising preference for personalised medicine in developed as well as developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase NGS market concentration over the forecast period.
04 June 2021
The rising frequency of bacterial and viral diseases coupled with increased focus on immunisation programmes are two main reasons that are expected to boost the global anti-infective vaccines market’s growth in the coming years.